SCHEMBL7302966

SCHEMBL7302966

N#Cc1ccc2c([O])c(C#N)c(C#N)cc2c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
IMPDH2 P12268 1/20 0.40
IMPDH1 P20839 1/20 0.40
CYP2A6 P11509 1/20 0.36
G6PD P11413 1/20 0.34
NCEH1 Q6PIU2 2/20 0.33
MIF P14174 2/20 0.33
MDM4 O15151 1/20 0.32
F2 P00734 1/20 0.31
PLG P00747 1/20 0.31
PLAU P00749 1/20 0.31
KLKB1 P03952 1/20 0.31
PRSS1 P07477 1/20 0.31
CYP19A1 P11511 1/20 0.31
GPR35 Q9HC97 1/20 0.31
CA9 Q16790 1/20 0.31
HIPK2 Q9H2X6 1/20 0.31
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7307452 0.79 CA1 (0.46) CA1CA2IMPDH2IMPDH1
SCHEMBL5249907 0.76 IMPDH2 (0.37) CA1CA2IMPDH2IMPDH1CYP2A6
SCHEMBL6397705 0.76 IMPDH2 (0.37) CA1CA2IMPDH2IMPDH1CYP2A6
SCHEMBL29420450 0.74 IMPDH2 (0.47) CA1CA2IMPDH2IMPDH1CYP2A6
SCHEMBL8852599 0.74 IMPDH2 (0.47) CA1CA2IMPDH2IMPDH1CYP2A6
SCHEMBL28274538 0.69 IMPDH2 (0.50) CA1CA2IMPDH2IMPDH1CYP2A6
SCHEMBL13037656 0.68 CA2 (0.55) CA1CA2IMPDH2IMPDH1CYP2A6
SCHEMBL818900 0.67 CA1 (0.55) CA1CA2IMPDH2IMPDH1CYP2A6
SCHEMBL29489126 0.67 CA1 (0.55) CA1CA2IMPDH2IMPDH1CYP2A6
SCHEMBL3027684 0.66 IMPDH2 (0.42) CA1CA2IMPDH2IMPDH1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed